Lineage Cell Therapeutics, Inc. - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 16, 2017

Attached files

file	filename
EX-32 - EXHIBIT 32 - Lineage Cell Therapeutics, Inc.	ex32.htm
EX-31 - EXHIBIT 31 - Lineage Cell Therapeutics, Inc.	ex31.htm
EX-23.1 - EXHIBIT 23.1 - Lineage Cell Therapeutics, Inc.	ex23_1.htm
EX-10.39 - EXHIBIT 10.39 - Lineage Cell Therapeutics, Inc.	ex10_39.htm
EX-10.38 - EXHIBIT 10.38 - Lineage Cell Therapeutics, Inc.	ex10_38.htm
10-K - BIOTIME, INC 10-K 12-31-2016 - Lineage Cell Therapeutics, Inc.	form10k.htm

Exhibit 21.1

List of Subsidiaries

Subsidiary	BioTime Ownership	Country

Cell Cure Neurosciences Ltd.	62.5%⁽¹⁾	Israel
ES Cell International Pte. Ltd.	100%	Singapore
LifeMap Sciences, Inc.	77.9%	USA
LifeMap Sciences, Ltd.	(2)	Israel
LifeMap Solutions, Inc.	(2)	USA
OrthoCyte Corporation	100%	USA
ReCyte Therapeutics, Inc.	94.8%	USA

(1)

Includes shares owned by BioTime and ES Cell International Pte Ltd.

(2)

LifeMap Sciences, Ltd. and LifeMap Solutions, Inc. are wholly-owned subsidiaries of LifeMap Sciences, Inc.